$2.06B
$282,000
0.0% of portfolio
11,800
Q2 2025
Reduced 9.92%
$6.14B
$423,000
0.0% of portfolio
1,400
Q2 2025
Reduced 26.32%
$13.3B
$282,000
0.0% of portfolio
1,433
Q2 2025
Reduced 97.3%
$345M
$554,000
0.0% of portfolio
46,100
Q2 2025
Reduced 12.85%
-
$0
0.0% of portfolio
-
Q2 2025
Added 7.59%
$2.64B
$739,000
0.0% of portfolio
32,800
Q2 2025
Added 3.8%
$1.2B
$128,000
0.0% of portfolio
4,200
Q1 2024
Reduced 12.5%
$373M
$527,000
0.0% of portfolio
31,300
Q2 2025
Added 7.19%
$300M
$24,000
0.0% of portfolio
2,900
Q2 2025
Reduced 68.48%
$16.1B
$324,000
0.0% of portfolio
5,043
Q2 2025
New
$410M
$536,000
0.0% of portfolio
39,700
Q4 2024
Added 12.09%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 6.25%
$5.02B
$259,000
0.0% of portfolio
3,700
Q1 2025
Reduced 39.34%
$288M
$496,000
0.0% of portfolio
31,100
Q2 2025
Reduced 7.16%
-
$0
0.0% of portfolio
-
Q2 2025
Added 2,831.25%
$17.3B
$458,000
0.0% of portfolio
6,052
Q2 2025
New
$2.96B
$57,000
0.0% of portfolio
500
Q4 2024
Reduced 80.0%
$737M
$617,000
0.0% of portfolio
13,300
Q2 2025
Added 3.1%
$4.82B
$542,000
0.0% of portfolio
5,800
Q2 2025
Reduced 61.07%
$255M
$213,000
0.0% of portfolio
22,500
Q2 2025
Added 7.66%
$29.1B
$583,000
0.0% of portfolio
497
Q2 2025
New
$400M
$540,000
0.0% of portfolio
31,200
Q2 2025
Added 9.86%
-
$0
0.0% of portfolio
-
Q2 2025
New
$821M
$614,000
0.0% of portfolio
100,500
Q2 2025
Added 28.35%
$1.98B
$247,000
0.0% of portfolio
4,500
Q2 2025
Added 309.09%
Mineralys Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 31.86%
$2.38B
$188,000
0.0% of portfolio
3,700
Q2 2025
Reduced 69.67%
$436M
$38,000
0.0% of portfolio
3,900
Q2 2025
New
$7.39B
$492,000
0.0% of portfolio
5,000
Q2 2025
Added 25.0%
$1.87B
$674,000
0.0% of portfolio
7,800
Q4 2024
Added 12.82%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 49.02%
$0
$328,000
0.0% of portfolio
23,861
Q1 2024
Reduced 24.11%
$11B
$176,000
0.0% of portfolio
562
Q2 2025
New
$279M
$435,000
0.0% of portfolio
38,900
Q2 2025
New
$4.22B
$1.15 Million
0.0% of portfolio
47,900
Q2 2025
Added 7.64%
$3.61B
$101,000
0.0% of portfolio
4,500
Q2 2025
Reduced 45.12%
$8.77B
$174,000
0.0% of portfolio
430
Q2 2025
New
$320M
$28,000
0.0% of portfolio
4,400
Q1 2025
New
$3.36B
$637,000
0.0% of portfolio
15,100
Q2 2025
Reduced 44.07%
$36.8B
$760,000
0.0% of portfolio
4,737
Q2 2025
New
$2.75B
$53,000
0.0% of portfolio
1,683
Q2 2025
New
Natures Sunshine Prods Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 12.71%
$4.58B
$434,000
0.0% of portfolio
9,700
Q2 2025
Added 7.78%
$7.87B
$21,000
0.0% of portfolio
403
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 61.36%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 16.94%
$2.04B
$53,000
0.0% of portfolio
9,964
Q2 2025
Reduced 92.49%
$7.52B
$97,000
0.0% of portfolio
141
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 10.7%
$12.3B
$276,000
0.0% of portfolio
1,288
Q2 2025
New